Why wait for generics? In praise of me-too drugs

Peter Kolchinsky, Ph.D

The Favors They Do Us: Charging Less in Other Countries Makes Drugs More Affordable in America

False Heroes — How PBMs Add Insult to the Injury of Insurance Cost-Sharing

Direct-to-Consumer (DTC) advertising: misnamed, misunderstood, and underappreciated

The strange and special case of epinephrine

The biotech social contract stipulates that all drugs must…

Hard Negotiating Tactics: Compulsory Licensing and Willingness to Deny

Let’s Throw a Patent-Burning Party

When a drug goes generic, it’s as if society has paid off a…